Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Return on Assets: 2014-2025

Historic Return on Assets for Ocular Therapeutix (OCUL) over the last 11 years, with Sep 2025 value amounting to -0.57%.

  • Ocular Therapeutix's Return on Assets fell 30.00% to -0.57% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.57%, marking a year-over-year decrease of 30.00%. This contributed to the annual value of -0.47% for FY2024, which is 2.00% down from last year.
  • Per Ocular Therapeutix's latest filing, its Return on Assets stood at -0.57% for Q3 2025, which was down 10.31% from -0.52% recorded in Q2 2025.
  • Ocular Therapeutix's 5-year Return on Assets high stood at -0.22% for Q2 2024, and its period low was -0.71% during Q2 2023.
  • Over the past 3 years, Ocular Therapeutix's median Return on Assets value was -0.45% (recorded in 2025), while the average stood at -0.46%.
  • As far as peak fluctuations go, Ocular Therapeutix's Return on Assets spiked by 88bps in 2021, and later fell by 30bps in 2025.
  • Quarterly analysis of 5 years shows Ocular Therapeutix's Return on Assets stood at -0.40% in 2021, then dropped by 15bps to -0.55% in 2022, then increased by 12bps to -0.43% in 2023, then increased by 8bps to -0.35% in 2024, then decreased by 30bps to -0.57% in 2025.
  • Its Return on Assets was -0.57% in Q3 2025, compared to -0.52% in Q2 2025 and -0.45% in Q1 2025.